Valturna Generic: When Will Generic Aliskiren and Valsartan Be Available?
This page is aggregated from FDA records, court filings and company announcements. Coded and designed by Dr. Brian Staiger, PharmD, BCPS
Updated October 9, 2026 How we build our data
Valturna Generic at a Glance
Four quick answers from FDA records and our estimate.
- When is the first generic expected? TBD no date yet What opens the door is not settled yet
- Has the FDA approved a generic? Not yet None in the FDA’s records yet
- When did the last patent end? July 2026 Every listed protection has ended
- Can you buy a generic today? Not yet No company lists one for sale
There is no expected month yet for generic aliskiren hemifumarate and valsartan. None is for sale yet.
Will the generic cost less?
Usually, but no company is recorded as having applied to make one yet, and a single company usually brings only a modest drop. See the price pattern
What should I do now?
Keep taking Valturna as prescribed. When a generic arrives, your pharmacy may switch you to it automatically, and it may look different. What a generic means for you
Our month is only an estimate based on available information, so we never name a day.
Valturna by the Numbers
- Reason
- Not yet clearNo generic application is on record yet. The month follows the patents and protections on record, which a challenge or a deal can end early.
- How sure
- Not rated Too early to rate.
- Price competition
- None filed yet No filers on record
- Brand sales
- Sales not reported
- FDA approved 2009 September 2009 FDA Orange Book
- Patents listed 1 all expired FDA Orange Book
Valturna’s Road to a Generic
Valturna has had the market to itself since the FDA approved it in September 2009 (Novartis Pharmaceuticals Corp). Its one listed patent has expired.
No generic application is on record yet. The month follows the patents and protections on record, which a challenge or a deal can end early.
Each bar runs from the brand’s approval to the day that protection ends. The green band is our projection for the first generic: a month, never a day, because legal dates move and a generic reaches shelves days to weeks after it is allowed. Sources: FDA Orange Book; the expected month from court records and company announcements.
Valturna Patents and FDA Protections
Every patent and exclusivity the FDA Orange Book lists for Valturna’s own applications. A protection running past the expected month does not mean the date is wrong: a settlement or a court ruling can let a generic in before a patent ends, and a patent on one formulation or use does not block every generic.
| Patent | What it covers | Protects until | Status |
|---|---|---|---|
| 8,168,616 | The product’s formulation | July 2026 | Expired |
Source: FDA Orange Book, application 022217. Patent numbers open the patent on Google Patents.
Who Is Lined Up to Make Generic Aliskiren Hemifumarate and Valsartan
Three steps stand between a brand and a generic you can buy: a company applies to the FDA, the FDA approves it, and the company starts selling it.
Applied to the FDA
No company is recorded as having applied to the FDA to make a generic Valturna yet.
Approved by the FDA
Not yet. The FDA has not approved a generic aliskiren hemifumarate and valsartan. Final approval often comes close to the day a generic can be sold.
For Sale in Pharmacies
Not yet. No company lists a generic aliskiren hemifumarate and valsartan for sale with the FDA.
Sources: how many companies have applied, from court records and company announcements; approved generics from the FDA Orange Book; tentative approvals from Drugs@FDA; what is for sale from the FDA NDC Directory. The FDA does not disclose an application before it approves it (21 CFR 314.430).
Valturna Price: What Pharmacies Pay and What Generics Usually Do
What a Generic Could Cost
How we estimate it. The national survey of what pharmacies pay (NADAC) has no recent price for Valturna, so we cannot show dollars. Here is the FDA’s finding of how far the price pharmacies pay usually falls as generic companies join: about 31% with one company, 44% with two, 73% with four and over 95% with six or more (the typical drop for every drug whose first generic came out from 2015 to 2017).
Median prices pharmacies paid for the generic (invoice prices), compared with the brand’s price before generic entry, from FDA’s 2019 analysis “Generic Competition and Drug Prices”. At the manufacturer’s price FDA found steeper drops (about 39%, 54%, 79% and over 95%), the figures quoted elsewhere on this tracker. A typical pattern, not a price quote for this medicine.
Valturna Strengths and Forms
| Strength | Form | How it is taken | Approved | Status |
|---|---|---|---|---|
| EQ 150MG BASE;160MG | Tablet | Oral | September 2009 | Discontinued |
| EQ 300MG BASE;320MG | Tablet | Oral | September 2009 | Discontinued |
Source: FDA Orange Book, Novartis Pharmaceuticals Corp.
What a Generic Valturna Means for You
Nothing Changes Until It Is in Pharmacies
Until a generic is actually for sale, keep filling Valturna as usual. When one arrives, there is nothing you need to sign up for.
Your Pharmacy May Switch You Automatically
Every state lets pharmacists fill a brand-name prescription with an FDA-approved generic rated as equivalent to it, and about 19 states require them to, unless your prescriber writes “dispense as written” or “brand medically necessary” on the prescription. Some states ask the pharmacist to tell you, or to get your OK first. A study of every state’s law has the details.
It Will Probably Look Different
US trademark law does not let a generic look exactly like the brand, so the color, shape or markings usually change. The active ingredient, strength and form are the same. An “authorized generic,” made by or for the brand’s own company, can look identical. The FDA explains.
Your Insurance May Change Too
Once a lower-cost version is available, many insurance plans charge more for the brand, or stop covering it. Your plan’s drug list (formulary) says how.
Until a generic is on US pharmacy shelves, be careful with websites that offer “generic Valturna”. The FDA warns that unlicensed online pharmacies sell counterfeit and unapproved medicines; its BeSafeRx page shows how to check a pharmacy.
Questions people ask about Valturna
Is there a generic for Valturna right now?
No. As of October 9, 2026 no generic aliskiren hemifumarate and valsartan is listed for sale in the FDA NDC Directory.
When will Valturna go generic?
There is no expected month yet. No generic application is on record yet. The month follows the patents and protections on record, which a challenge or a deal can end early.
Will generic aliskiren hemifumarate and valsartan be the same as Valturna?
Yes in the ways that matter: the same active ingredient, strength and form, with proof that it reaches your blood the same way. Inactive ingredients can differ, which is why some people notice a different look or taste.
How much will the generic cost?
Nobody can say for sure before launch. No company is recorded as having applied to the FDA to make one yet, and a single company usually brings only a modest drop.
Has the FDA approved a generic Valturna?
Not yet. The FDA Orange Book lists no approved generic version of Valturna.
When does the Valturna patent expire?
One patent is listed for Valturna in the FDA Orange Book; it runs to July 2026. A patent date is not the launch date: settlements and court rulings often bring a generic earlier, and FDA approval or a company’s own plans can make it later. The expected window on this page (a date that is not known yet) weighs all of that.
Changes to This Projection
- First generic expected a date that is not known yet on this month’s schedule. A line is added here whenever a monthly update moves the month, the reason or how sure it is.
Every change to the expected month is logged here with the month we saw it.
Also Going Generic
- KyleenaLevonorgestrelSeptember 2029
- BelsomraSuvorexantNovember 2029
- Synjardy XREmpagliflozin and Metformin2032 to 2033
- XepiOzenoxacinJanuary 2032
- OxbrytaVoxelotorJanuary 2034
- ExblifepEnmetazobactam and Cefepime HydrochlorideNovember 2034
About Valturna
- Generic name aliskiren hemifumarate and valsartan
- How it is taken By mouth
- Company Novartis Pharmaceuticals Corp
- More drugs Brand-name drugs starting with V
- Have a question? A pharmacist answers, free. Ask about Valturna
Sources. The expected month: FDA Paragraph IV Patent Certifications list, federal court records, company announcements and securities filings (settlement dates, launch plans, sales). The record on this page: FDA Orange Book, Drugs@FDA (tentative approvals), FDA NDC Directory, FDA, Generic Competition and Drug Prices (2019). Updated October 9, 2026. Information, not medical advice.